Turn on the news and you're likely to hear talk of study after study shedding new light and information on important medical issues. Yet, it's just a study. The medical discoveries discussed excitedly never make it to the next step. You're not sitting in your doctor's office, receiving treatment or console based on the breakthrough in stem cell research you heard about years ago.
Why?
Just because a study is published in a scientific journal doesn't mean it is research ready to be implemented. The 1st role of scientific law is that hypothesis must be tested and the results reproduced in order to move up the chain of scientific validation. One of the main problems associated with reproducing studies and experiments is locating the right manufacturers or products. It might seem like a simple problem. However, it is extremely complicated, expensive and time-consuming.
What?
A report by economists in 2015 stated that 50% of studies published in scientific journals can never be reproduced in other labs. This creates a scenario where billions of dollars are wasted every year in failed research projects that can't be reproduced. Not only is money wasted, but also the valuable time that could be spent researching new problems and discovering cures.
How?
Biomedical research suppliers hide the identity of manufacturers from the scientists conducting the cutting-edge research. Suppliers re-brand the products being received from the manufacturer. They do this in attempts to dominate the market. This creates severe mayhem for the scientists desperately trying to reproduce a study in order to advance the initial research and success achieved from prior research projects. Researchers often have to inadvertently test and retest and then again retest the same exact product due to different suppliers all rebranding the same product under their own label while hiding the source of the manufacturer. The end result of this redundant testing are countless hours and financial resources lost. This leads to projects running out of budget and being shelved without ever making any progress. Plus, that is time not spent looking for new scientific breakthroughs that can treat patients in need. This would be annoying on any level within most industries. Yet, it is beyond tragic and inhumane in the context that people are dying, suffering because they can't get access to new scientific advancements and treatments.
What can be done to help solve this crisis?
One World Lab provides access to original manufacturers while providing access to their products, highlighting their transparency, and facilitating open, clear international dialogue between researchers around the globe.
One World Lab has actually created this very platform that is seeking to change the way researchers approach scientific testing and finding manufacturers. They offer a platform where only original manufacturers are represented. In addition, they have a processing center in California that allows researchers the ability to purchase just a sample instead of an entire vial. Their process and distribution service also serves to reduce overall cost and time for researchers.
One World Lab is seeking to make their software available to Biomedical researchers around the world for free. However, they lack the adequate funding to complete the software. It is chilling to realize that professional athletes earn millions and millions of dollars a year yet medical research struggles to gain public support, with most scientists working to make $60,000 a year. Major scientific breakthroughs and cures are only an unknown manufacturer away from the labs seeking quality reagents needed to reproduce important studies.
“We have created an egalitarian platform at One World Lab that united manufacturers and researchers,” exclaimed Mike Simson, CEO of One World Lab. He later stated, “If we do nothing now then the situation in biomedical research will become much more dire and people will continue to needlessly suffer.”
Unknown manufacturers, shelved projects, high expenses and redundant testing of the same reagents over and over again is eliminated with the solution being presented by One World Lab.
One World Labs is currently raising funds to finish developing their software program. They only need to raise a grand sum of $60,000 to be able to eliminate this human health and biomedical research crises, through their software, which is an interactive validation system that promises to create a standard for product performance and quality.
Why do we question why more advancements have not been made in the treatment of cancer and other serious illnesses yet remain unwilling to do our small part to ensure our researchers, our true heroes, are able to gain access to basic research supplies?
We must do our part.